Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Motor Activity 12Breast Neoplasms 9Neoplasms 6Leukemia, Myeloid, Acute 3Prostatic Neoplasms 2Patient Compliance 2Neoplasm Metastasis 2Fatigue 2Depression 2Colorectal Neoplasms 2Brain Neoplasms 2Weight Loss 1Weight Gain 1Smoking Cessation 1Peripheral Nervous System Diseases 1Overweight 1Ovarian Neoplasms 1Obesity 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Lung Neoplasms 1Insulin Resistance 1Infratentorial Neoplasms 1Fallopian Tube Neoplasms 1Disease 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Bone Metabolism Biomarkers 1Body Weight Changes 1

Interventions

antineoplaston AS 2-1 4antineoplaston A10 4Cyclophosphamide 4Cisplatin 4Temozolomide 3Radiotherapy 3dactolisib 2Vincristine 2Filgrastim 2Everolimus 2Etoposide 2Bevacizumab 2spartalizumab 1sargramostim 1pasireotide 1ganitumab 1gallium Ga 68 dotatate 1fosbretabulin 1cixutumumab 1belzutifan 1aldesleukin 1Topotecan 1Thiotepa 1TH 302 1Sunitinib 1Standard of Care 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuroectodermal Tumors, Primitive × Exercise × Clear all
NCT01878617 2025-11-13

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
660 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡